Hipwell A E, Sturt J, Lindenmeyer A, Stratton I, Gadsby R, O'Hare P, Scanlon P H
CLAHRC-WM, Warwick Business School, University of Warwick, Coventry, UK.
Florence Nightingale School of Nursing and Midwifery, King's College London, London, UK.
BMJ Open. 2014 Dec 15;4(12):e005498. doi: 10.1136/bmjopen-2014-005498.
To examine the experiences of patients, health professionals and screeners; their interactions with and understandings of diabetic retinopathy screening (DRS); and how these influence uptake.
Purposive, qualitative design using multiperspectival, semistructured interviews and thematic analysis.
Three UK Screening Programme regions with different service-delivery modes, minority ethnic and deprivation levels across rural, urban and inner-city areas, in general practitioner practices and patients' homes.
62 including 38 patients (22 regular-screening attenders, 16 non-regular attenders) and 24 professionals (15 primary care professionals and 9 screeners).
Antecedents to attendance included knowledge about diabetic retinopathy and screening; antecedents to non-attendance included psychological, pragmatic and social factors. Confusion between photographs taken at routine eye tests and DRS photographs was identified. The differing regional invitation methods and screening locations were discussed, with convenience and transport safety being over-riding considerations for patients. Some patients mentioned significant pain and visual disturbance from mydriasis drops as a deterrent to attendance.
In this, the first study to consider multiperspectival experiential accounts, we identified that proactive coordination of care involving patients, primary care and screening programmes, prior to, during and after screening is required. Multiple factors, prior to, during and after screening, are involved in the attendance and non-attendance for DRS. Further research is needed to establish whether patient self-management educational interventions and the pharmacological reformulation of shorter acting mydriasis drops, may improve uptake of DRS. This might, in turn, reduce preventable vision loss and its associated costs to individuals and their families, and to health and social care providers, reducing current inequalities.
考察患者、卫生专业人员及筛查人员的经历;他们与糖尿病视网膜病变筛查(DRS)的互动及理解;以及这些如何影响参与率。
采用多视角、半结构化访谈及主题分析的目的抽样定性设计。
英国筛查项目的三个地区,具有不同的服务提供模式、少数族裔情况及城乡和市中心地区的贫困水平,涉及全科医生诊所及患者家中。
62人,包括38名患者(22名定期筛查参与者,16名非定期筛查参与者)及24名专业人员(15名初级保健专业人员和9名筛查人员)。
参与筛查的影响因素包括对糖尿病视网膜病变及筛查的了解;未参与筛查的影响因素包括心理、实际及社会因素。确定了常规眼部检查所拍照片与DRS照片之间存在混淆。讨论了不同的地区邀请方法及筛查地点,便利性和交通安全性是患者的首要考虑因素。一些患者提到散瞳滴眼液带来的剧痛和视觉干扰是阻碍他们参与筛查的因素。
在这项首次考虑多视角经验描述的研究中,我们确定在筛查前、筛查期间及筛查后,需要患者、初级保健和筛查项目之间进行积极的护理协调。筛查前、筛查期间及筛查后,多种因素影响DRS的参与和未参与情况。需要进一步研究以确定患者自我管理教育干预措施以及短效散瞳滴眼液的药物重新配方是否可以提高DRS的参与率。这反过来可能会减少可预防的视力丧失及其给个人、家庭以及卫生和社会护理提供者带来的相关成本,减少当前的不平等现象。